MedTrace Logo

Memory Training Intervention for Breast Cancer Survivors

NCT01497015 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2023-02-23

No results posted yet for this study

Summary

This is a randomized controlled trial to evaluate the ACTIVE memory training intervention and ACTIVE speed of processing training to waitlist, no-contact control conditions. Specific aims and hypotheses are:

Aim 1: Evaluate the acceptability and usefulness of the ACTIVE memory intervention among Breast Cancer Survivors (BCS).

Hypothesis 1: BCS assigned to the memory intervention arm will perceive the intervention as more acceptable and useful than BCS assigned to the attention control condition.

Aim 2: Establish preliminary efficacy of the ACTIVE memory training intervention relative to the attention control and no-contact control conditions.

Hypothesis 2: Memory training will result in greater memory enhancement immediately post and 2-months post-intervention relative to attention control or no-contact control conditions.

Conditions

Interventions

BEHAVIORAL

memory training

10 1-hour sessions over 6-8 weeks

BEHAVIORAL

speed of processing training

10 1-hour sessions delivered over 6-8 weeks

BEHAVIORAL

waitlist control

Breast cancer survivors will receive the speed of processing training compact disc in the mail after study completion.

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Diane Von Ah, PhD, RN, CNA · Indiana University

  • Andrew Saykin, PsyD · Indiana University

  • Frederick Unverzagt, PhD · Indiana University

  • Janet Carpenter, PhD, RN · Indiana University

  • Patrick Monahan, PhD · Indiana University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-09-30
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01497015 on ClinicalTrials.gov